Sensitivity and Specificity of Xpert MTB/RIF Ultra - Trial NCT06058065
Access comprehensive clinical trial information for NCT06058065 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Tuberculosis. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Assiut University
Timeline & Enrollment
N/A
Dec 11, 2023
Dec 25, 2024
Primary Outcome
Sensitivity and Specificity of Xpert MTB/RIF Ultra
Summary
To estimate diagnostic accuracy of Xpert Ultra and Xpert MTB/RIF for extrapulmonary
 tuberculosis and rifampicin resistance in adults suspected to be infected with mycobacterium
 tuberculosis. In addition, this study will estimate the pattern of rifampicin resistance
 among TB cases in Assiut population.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06058065
Non-Device Trial